Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Real-time Estimate Cboe BZX
Other stock markets
 10:22:02 2024-05-22 am EDT 		5-day change 1st Jan Change
37.48 USD -0.50% Intraday chart for Celldex Therapeutics, Inc. -7.00% -5.80%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bullish

Bullish

Resistance 42.56 51.88 51.88
Spread/Res.-12.22%-27.99%-27.99%
Spread/Supp.+5.93%+5.93%+10.11%
Support 35.27 35.27 33.93

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. Charts Celldex Therapeutics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW